GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Days Sales Outstanding

Invitro International (Invitro International) Days Sales Outstanding : 83.69 (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Days Sales Outstanding?

Invitro International's average Accounts Receivable for the three months ended in Jun. 2097 was $0.17 Mil. Invitro International's Revenue for the three months ended in Jun. 2097 was $0.18 Mil. Hence, Invitro International's Days Sales Outstanding for the three months ended in Jun. 2097 was 83.69.

The historical rank and industry rank for Invitro International's Days Sales Outstanding or its related term are showing as below:

IVRO's Days Sales Outstanding is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 69.88
* Ranked among companies with meaningful Days Sales Outstanding only.

Invitro International's Days Sales Outstanding increased from Jun. 2096 (0.00) to Jun. 2097 (83.69).

Invitro International Days Sales Outstanding Historical Data

The historical data trend for Invitro International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Days Sales Outstanding Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Days Sales Outstanding
Get a 7-Day Free Trial - - - - -

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 87.36 83.69

Competitive Comparison of Invitro International's Days Sales Outstanding

For the Diagnostics & Research subindustry, Invitro International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invitro International's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Invitro International's Days Sales Outstanding falls into.


Invitro International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Invitro International's Days Sales Outstanding for the fiscal year that ended in Sep. 2096 is calculated as

Days Sales Outstanding (A: Sep. 2096 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2095 ) + Accounts Receivable (A: Sep. 2096 )) / count ) / Revenue (A: Sep. 2096 )*Days in Period
=( (0 + 0) / 1 ) / 1.1*365
=0 / 1.1*365
=0.00

Invitro International's Days Sales Outstanding for the quarter that ended in Jun. 2097 is calculated as:

Days Sales Outstanding (Q: Jun. 2097 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2097 ) + Accounts Receivable (A: Jun. 2097 )) / count ) / Revenue (A: Jun. 2097 )*Days in Period
=( (0.157 + 0.175) / 2 ) / 0.181*365 / 4
=0.166 / 0.181*365 / 4
=83.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International  (OTCPK:IVRO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Invitro International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Invitro International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Invitro International (Invitro International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Days Sales Outstanding
Comparable Companies
ASX:LSH IDTA TSXV:TELO ASX:CTE XSAT:ALPH BOM:526301 ABMC BOM:541299 BOM:526546 NGM:LIFE B XLRM TSXV:AVCR TEAR WAR:BMX XKRX:271850 TSXV:MBI.H WAR:IGN BOM:526504 BOM:516110 SGX:505
Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Website
https://www.invitrointl.com
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.